Episode Details
Back to Episodes
Double CLICK for BP control in CKD 4
Description
The Filtrate:
Joel Topf
Swapnil Hiremath
Jennie Lin (who was only there because her plans got boxed by covid)
Jordy Cohen
Josh Waitzman
Special Guest:
Rajiv Agarwal (@AgarwalRajivMD)
Editor:
Joel Topf
Show Notes:
NephJC discussion of CLICK: http://www.nephjc.com/news/click4chlorthalidone
CLICK Visual abstract: http://www.nephjc.com/news/2021/12/7/the-click-visual-abstract
Hawthorne effect: https://en.wikipedia.org/wiki/Hawthorne_effect
A nice discussion run in periods in clinical trials: http://www.nephjc.com/news/run-in-period
The ABCD trial Agarwal used to describe the need for a beta blocker to enroll in the trial, but it looks like a review article https://pubmed.ncbi.nlm.nih.gov/12574784/
Canadian trial showing that atenolol did as well as evidence based beta blockers: https://pubmed.ncbi.nlm.nih.gov/31495887/ Associated editorial by Agarwal: https://pubmed.ncbi.nlm.nih.gov/31578572/
Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate by Mark A Peterzan https://pubmed.ncbi.nlm.nih.gov/22547443/
HCTZ vs Chlorthalidone compete to the death: VA CSP Study No. 597: Diuretic Comparison Project https://www.research.va.gov/programs/csp/597/default.cfm
Effectiveness versus Efficacy Trials: https://www.ncbi.nlm.nih.gov/books/NBK44024/
Foundation on Apple TV+:
Listen Now
Love PodBriefly?
If you like Podbriefly.com, please consider donating to support the ongoing development.
Support Us